Let the uprising begin!! First stop, the annual
love fest, I mean, meeting, when Sir Sidney tells us
about the "bold, strategic moves LLY will make," and
how the "companies and employees will make us into
the top pharma company (not, of course, based on any
financial metrics--maybe based on altruism?) Of course, I
expect the line, "Wall ST obviously doesn't know how to
value us." Thats the same BS I heard when I was there
in the early 90's before Tobias, AN OUTSIDER, made
something happen. I sense internal implosion at Lilly, Us
(Go it alone, Wall St doesn't like us, etc.) v. them
(the big evil mergers).
I'm surprised we
haven't seen something out of Indy. The farther LLY
falls, the more acquisition-bait they become--but don't
get your hopes up mgmt will drive--it will be one
ugly hostile takeover if it happens.
I wish I
could bail but, as a former higly overpaid manager, I'm
stuck until I can stomach a REASONABLE capital loss
(you can only deduce so much).
The best thing that can happen is for LLY to test
60 1/2 one more time this week (sardistic, I know)
and go back up to around 68-70 next week instead of
hoovering around 61+ like this.
Did you people hear
that BMY is trying to settle Taxol law suit out of
court? If this happens, BMY might be free to merge/take
over (?LLY) sooner than the expected March.
yep to bottomdweller's comment--5 yr study--they
will probably start doing analyis at end of yr
2--could be good news if seperation at that
Evista is slowly on its way to a $1b but taking the 2
lane hwy v. the interstate.
problem is Evista, along with Tamoxifen, may be the first
truly preventative drug. Managed care hates it but
women and the media could make them look bad if Evista
gets a nod for breast cancer. What concerns me are the
MDs. MD's are, for the most part, plumbers (i.e.
fixers). YOu're sick, you go to the doc and get the leak
repaired. It's a different mentality (esp for men) to
prescribe a drug long term that prevents a disease yet
doesn't immediately solve a problem (like high
cholestrol). Who's going to pay for this 15 yrs benefit? The
pharmacoeconomics have better be solid or mgd care punts.
help MD's, LLY is targeting not just family MD's but
OB'/GYN who 1)are increaingly becoming more female
dominated and 2)are more use to the prevention discussion.
There is an ongoing trial to compare Tamoxifen
and Evista in Breast Ca prevention. The bad news is
the trial will take another ?5years to complete.There
won't be any news on that front for a long while
(unless the study is stopped prematurely due to
unexpected positive or negative finding).
Since you are a former employee, why is lly lying
about the Humulin, and insisting that everyone can
switch and no one has a problem on it? What has happened
to this once fine company? A friend of mine called
them today to find out why no one can find the pork
insulin here in the states, that they insist we should be
able to use, if we can't use the Humulin, and she said
they were transferring her from one office to another,
and it was almost like they were trying to come up
with an answer. They told her they were still making
it, here in the states, but they did not know where.
WHAT!!!!!. Granted, Humulin works for some, but when you
make a claim that everyone can use it and no one has a
problem on it, you had better be ready to back it up, and
they cannot back it up. The media is working on this
story about the humulin, someone from the press called
me last Friday. I will swear this on a Bible to you.
LLY has dug themselves a deep hole, with this
coverup. I have nothing against you people, I am just
trying to warn you, LLY has been found out. I am not the
only one contacting Senators, Congresspeople, the
media, etc. There is a massive audience going to hear
this story soon. I feel as sorry for you people as I
do for the diabetics suffering who have been forced
to use the Humulin, since they stopped producing the
Iletin I. You put your faith and trust in this company
by buying lly shares, just as we have for decades
had faith in them and trusted their superior
insulins. For years they were a superior company, but they
have dug their own grave with this coverup.
fair question. you are right--not every drug
works in all people. Usually, there's almost always an
alternative or a new drug on the horizon.
line is (i think) your on pork insulin and can't
tolerate genetically engineered insulin (Humulin is one,
Novo also has one with AVE on the way with another)
Have you tried these?. I'm assuming (don't remember)
LLY is last remain pork insulin producer.
remeber much discussion about closing down Iletin
production but wasn't directly involved. Probably, in the
end, the goal was to get people to Humulin b/c they
were afraid to go or the MD was ignorant and wouldn't
switch them and I'm sure the clinical people would make
the claim everyone SHOULD be able to use. Safe to say
some financial parameters also had something to do
No doubt, with no other supply, this
is a huge moral conundrum. Sorry, I'm a capitalist
at heart and want to see my options increase not
slide into the north atlantic with the Titanic. LLY has
every right to stop production--they are not the govt.
But there are issues, particularly PR as it relates
to the moral dilemna, to manage. IF I MADE THIS
DECISION, I WOULD BE READY TO HANDLE THE PR. I guess we'll
find out soon if your story comes to life how prepared
Also, if there's really a huge, animal
insulin mkt (you've claimed 300k users), some mfgr should
jump in, right? sounds like an opportunity???
Regardless, your story does make some sense now--I think most
board participants have issues with your sensationalism
on PRozac et al which are groundless. You stated the
facts on Humulin clearly. But unfortunately for your
crusade, I the market is emotionless is the long run--at
worse, LLY gets a black eye. It will heal.